ZTS PEER ANALYSIS

Zoetis Inc — metric-by-metric comparison with peers and the industry median

ZTSZoetis Inc

🇺🇸 USA · US · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

ZTSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ZTS	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
P/E	11.95●	25.00	22.08	—	—	46.82	21.37
P/B	9.77	2.13	4.32	-0.88●	0.80	3.47	1.82
EV/EBITDA	9.65	11.99	14.64	4.05●	33.84	14.07	12.26
P/S	3.32	3.02	3.93	0.21●	5.03	1.86	2.09

Financial Health
Metric	ZTS	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
Current Ratio	3.15	1.51	3.66●	1.32	1.73	1.33	2.22
Debt/Equity	285.7%	40.5%	17.0%	-1,010.0%●	5.9%	41.0%	46.3%
NetDebt/EBITDA	1.81	1.38	0.09	3.71	-0.10●	1.10	1.24

Profitability
Metric	ZTS	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
Net Margin	27.8%●	12.1%	17.8%	-13.5%	-3.6%	4.0%	4.0%
ROE	67.0%●	8.5%	20.9%	—	-0.6%	8.7%	6.4%
ROA	18.1%●	4.9%	15.1%	-4.7%	-0.5%	4.8%	3.4%
EBITDA Margin	42.4%	28.5%	27.0%	60.0%●	14.8%	14.3%	18.2%

Growth + Dividend
Metric	ZTS	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
Rev. Growth	2.4%	-1.7%	-3.4%	-9.9%	-2.3%	16.3%●	7.5%
NI Growth	5.0%	-10.1%	-5.9%	—	—	146.6%●	5.0%
Div. Yield	2.8%●	1.5%	1.6%	0.0%	2.6%	0.0%	2.0%
Payout	33.6%	11.8%	36.3%	0.0%	-365.1%	0.0%	0.8%

Valuation
Metric	ZTS	UTHR	VTRS	NBIX	ELAN	ALKS	Ind. Median
P/E	11.95●	20.38	—	26.95	—	59.40	21.37
P/B	9.77	4.45	1.34●	5.29	1.95	5.18	1.82
EV/EBITDA	9.65●	—	12.54	17.90	21.22	36.69	12.26
P/S	3.32	8.28	1.35●	5.81	2.59	5.81	2.09

Financial Health
Metric	ZTS	UTHR	VTRS	NBIX	ELAN	ALKS	Ind. Median
Current Ratio	3.15	4.79●	1.60	2.93	2.16	2.27	2.22
Debt/Equity	285.7%	—	97.9%	11.9%●	61.4%	90.3%	46.3%
NetDebt/EBITDA	1.81	—	4.89	-0.95●	4.66	3.87	1.24

Profitability
Metric	ZTS	UTHR	VTRS	NBIX	ELAN	ALKS	Ind. Median
Net Margin	27.8%	40.6%●	-2.0%	21.6%	-4.9%	9.8%	4.0%
ROE	67.0%●	20.3%	-2.0%	22.5%	-3.8%	9.4%	6.4%
ROA	18.1%●	17.8%	-0.8%	15.6%	-1.8%	4.8%	3.4%
EBITDA Margin	42.4%	54.1%●	17.6%	30.8%	15.6%	17.7%	18.2%

Growth + Dividend
Metric	ZTS	UTHR	VTRS	NBIX	ELAN	ALKS	Ind. Median
Rev. Growth	2.4%	5.9%	1.6%	28.6%●	10.5%	3.2%	7.5%
NI Growth	5.0%	6.3%	—	118.6%●	—	-56.7%	5.0%
Div. Yield	2.8%	—	3.0%●	—	—	—	2.0%
Payout	33.6%	—	-188.0%	—	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ZTS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.